ACRE Publications

Access book chapters, journal articles, editorials and commentaries, and reports contributed to and produced by ACRE investigators and members. 

Book chapters

W Hall. Cannabis and cannabinoids for medical, scientific and 'recreational' use: risks and benefits. INCB Report 2018. [Full text]


Journal articles


Khademi Sedigh, Hallinan Christine Mary, Conway Mike, Bonomo Yvonne. Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review. J Med Internet Res. Published 27 February 2023.  [Full Text]


Gharbi Kayvan Ali, Bonomo Yvonne Ann, Hallinan Christine Mary. Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach. IJERPH. 2023;20(5):4087. [Full Text]


Khademi Habibabadi S, Hallinan C, Bonomo Y, Conway M. Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques. Review. J Med Internet Res. 2022;24(11):e35974. [Full Text]


Hallinan C, Khademi Habibabadi S, Conway M and Bonomo Y. Social media discourse and internet search queries on cannabis as a medicine: A systematic scoping review. Plos One Collection - Chemical Tools & Probes. Published 20 January 2023. [Full Text]


J Martin and J Patel. Complementary and alternative therapies in the palliative setting.  Internal Medicine Journal. Published October 2022 [Full text]


J Lawson, J Martin, T O'Brien, M Graham, E Renaud, D Jones, J Freeman and N Lawn. Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience.  Br J Clin Pharmacol. 2022; 1-13 [Full text]


Y Bonomo, J Martin, A Norman, P Galettis, L Collins, H O'Neill, J Trinca, N Strauss and D Castle. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study. SpringerLink. Published 18 December 2021 [Full text]


J Martin and Hayes C. Lack of efficacy of cannabidiol for relieving back pain: time to re-set expectations? Medical Journal of Australia, 214 360-361 (2021). [Full text]


J Martin, N Solowij, J Schneider, P. Galettis and Z Liu. Model-based analysis on systemic availability of coadministered cannabinoids after controlled vaporised administration. Internal Medicine Journal 2020; 50 846-853. [Full Text]


J Martin, M Graham, S Bird, Z Howard, M Dobson, C Lucas, J Schneider,  K Eager and K Palazzi. NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes. Internal Medicine Journal.  First published: 27 November 2021. [Full text]


J Martin, R Galettis, C Hill, et al. Clinical trials with cannabis medicines - Guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience. BMC Part of Springer Nature. Published 17 November 2020. [Full text]


M Graham, C Lucas, J Schneider, J Martin and W Hall. Translational hurdles with cannabis medicines. PDS Pharacoepidemiology and Drug Safety, Pharmoepidemiology 6th Edition. April 2020, 6th Edition. [Full text]


N Solowij. Weighing the dangers of cannabis: As interest builds in the potential health benefits from the plant, accumulating evidence confirms that taking the drug also carries risks. Nature International Journal of Science. Nature 572, S16-S18 (2019). [Full text] 


N Solowij, S Broyd, L Greenwood, H van Hell, D Martelozzo, K Rueb, J Todd, Z Liu, P Galettis, J Martin, R Murray, A Jones, P Michie and R Croft. A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. European Archives of Psychiatry and Clinical Neuroscience. February 2019, Volume 269, Issue 1, pp 17-35. [Full text]


M Williams, J Martin and P Galettis. A Validated method for the detection of synthetic cannabinoids in oral fluid. Journal of Analytical Toxicology Volume 43, Issue 1, January 2019. [Full text]


N Solowij. Peering Through the Haze of Smoked vs Vaporized Cannabis—To Vape or Not to Vape? The Journal of the American Medical Association (JAMA Network). JAMA Netw Open. 2018;1(7):e184838. November 30, 2018. [Full text]


C Lucas, P Galettis and J Schneider. The pharmacokinetics and the pharmacodynamics of cannabinoids. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84 (11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. [Full text]


Z Liu and J Martin. Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84 (11):2483-2487. doi: 10.1111/bcp.13635. Epub 2018 Jun 7. [Full text]


L Dryburgh, N Bolan, C Grof, P Galettis, J Schneider, C Lucas and J Martin. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. doi: 10.1111/bcp.13695. Epub 2018 Aug 1. [Full text]


C Grof. Cannabis, from plant to pill. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2463-2467. doi: 10.1111/bcp.13618. Epub 2018 May 24. [Full text]


J Martin and Noel Cranswick. Care and concern with cannabinoids used therapeutically. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2455-2457. doi: 10.1111/bcp.13724. Epub 2018 Aug 22. [Full text]


J Martin, Y Bonomo and A Reynolds. Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of Physicians. The Medical Journal of Australia. Med J Aust 2018; 208 (3): 107-109. || doi: 10.5694/mja17.01004. [Full text]


W Hall and M Farrell. The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications. The Medical Journal of Australia. Med J Aust 2018; 209 (5): 209-210. || doi: 10.5694/mja18.00445. [Full text]


C Lucas, P Galettis, S Song, N Reuter, J Schneider and J Martin. Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer. Clinical Therapeutics 2018;40(9):1442-1447.  [Full text]


J Martin, J Schneider, C Lucas and P Galettis. Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction? Clinical Pharmacokinetics 2018;57(5):529545.  [Full text]


C Lucas and J Martin. Predicting Drug Interactions in Addiction Treatment. Internal Medicine Journal 2017;47(8):872-878.  [Full text]


Y Bonomo, J Souza, A Jackson J Crippa, N Solowij. Clinical issues in cannabis use. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2495-2498. doi: 10.1111/bcp.13703. Epub 2018 Aug 2017. [Full text]


J Martin and C Hayes. Lack of efficacy of cannabidiol for relieving back pain: time to re-set expectations? The Medical Journal of Australia. Published online: 3 May 2021. [Full text]


Editorials and commentaries

J Martin and N Talley. Cannabinoid use in practice in Australasia - better guidance and new drug information systems will be essential for prescribers. British Journal of Clinical Pharmacology. April 2019. [Full text]


J Martin. Australia building the evidence based on medical cannabinoids. Health Europa. April 2019. [Full text]


J Martin. Yes we cannabis? High stakes for medical professionals, politicians and the community. Asia and the Pacific Policy Society Policy Forum. [Full text]


W Hall. Medicinal cannabis should be more than pot luck: How can cannabis-based medicines be made safe, effective, and affordable? Asia and the Pacific Policy Society Policy Forum. [Full text]


J Martin. As CBD skyrockets in popularity, scientists scramble to understand how it's metabolized. Nature Medicine. [Full text]


J Martin and W Hall. Easier patient access to medical cannabis carries risks as well as benefits. PubMed Letter.



W Hall. Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). [Full text]

ACRE • All Right Reserved

Website by mudbath